koolgal
07-19 17:20
🌟🌟🌟I like $WUXI BIO(02269)$ as it is China's largest biologics company and one of the top 5 in the world specialising in contract research, development and manufacturing in this sector.

WuXi Biologics is expanding with new facilities in Ireland, US, Chengdu and Singapore.

WuXi Biologics has strong financial momentum with revenue growing 16.7% YoY in 2025 and net profit up 17.9% YoY.  It has also seen explosive growth in Bi and multi specific antibody revenue with revenue increasing by 120% YoY, representing 20% of total revenue.

I believe that WuXi Biologics has lots of exponential growth ahead in the future and would be a great stock to add to my watch list.

@Tiger_comments @Tiger_SG @TigerStars

AI Trade Cools: SOX Drops 4.3%, TSMC Net Profit Surges 77% Yet Closes Lower — Hardware Oversold?
US AI trades broadly sold off Thursday: Nasdaq −1.47%, SOX −4.3%, TSMC closing lower despite Q2 net profit +77% YoY; memory, storage, and chips hit hard as VIX jumped 6.76%. But ASML's raised guidance shows AI-compute demand stays firm. The fear isn't collapsing demand — it's when hyperscaler capex becomes revenue and cash flow. As earnings beats fail to move stocks, the AI trade may be shifting from "chasing hardware" to "validating returns." Profit-taking, or a real capex inflection?
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment
10